HBsAg, Anti-HBs, Anti-HCV and Anti-HIV seroprevalence among patients admitted to our hospital; five-year retrospective data

Basit Öğe Kaydı
dc.contributor.authorAvciküçük, H.
dc.contributor.authorDülger, D.
dc.contributor.authorAydin, F.
dc.contributor.authorSari, Ü.S.
dc.date.accessioned2024-09-29T16:16:01Z
dc.date.available2024-09-29T16:16:01Z
dc.date.issued2022
dc.departmentKarabük Üniversitesien_US
dc.description.abstractObjective: Viral hepatitis and human immunodeficiency virus (HIV) infections are important health problems in our country as well as all over the world. We aimed to investigate the distribution of seropositivity of HBsAg, anti-HBs, anti-HCV and anti-HIV according to years, genders and age groups in patients who applied to our hospital. Methods: Results of HBsAg, anti-HBs, anti-HCV and anti-HIV tests performed during 2015-2019 in our hospital were reviewed retrospectively. 77,562 serum samples were studied for HBsAg, 45,045 for anti-HBs, 73,223 for anti-HCV and 71,061 for anti-HIV of a total of 266,891 samples. The tests were analysed using chemiluminescent microparticle immunoassay (Architect i 1000, Abbott, USA) and electro-chemiluminescence immunoassay (Cobas 6000,Roche Diagnostic GmbH, Germany) methods. Data were collected from the database of our hospital. Data were analyzed using the SPSS software ver. 24.0. Chi-Square (?2) analysis and Fisher’s Exact test were used for comparison of categorical variables. The p<0.05 was considered statistically significant.Results: HBsAg, antiHBs, anti-HCV and anti-HIV positivity were 2.3 % (1,808/77,562), 46.6% (20,975/45,045), 0.6% (456/73,223) and 0.05% (35/71,061) respectively. Of the 1,808 patients were positive for HBsAg, 55% were males, 45% were females. Of the 456 anti-HCV positive patients, 63.6% were females and 36.4% were males. When assessed by age groups, HBsAg positivity was found to be the highest in the age group 31-50 (38.1%) and lowest in the age group ? 18 (0.6%). Anti-HCV positivity was found to be the highest in the age group ?65 (32%) and lowest in the age group ? 18 (2%). All patients who were found to be anti-HIV positive were male and the highest positivity rate was between the ages of 19-30. Conclusion: Our HBsAg, anti-HBS, anti-HCV and anti-HIV results were found to be similar with the country statistical data. There was significant difference in the seropositivity of HBsAg (p<0,001), anti-HCV (p<0,05) and anti-HIV (p<0,001) during the measurement period. © 2022,Turk Hijyen ve Deneysel Biyoloji Dergisi. All Rights Reserved.en_US
dc.identifier.doi10.5505/TurkHijyen.2022.67355
dc.identifier.endpage408en_US
dc.identifier.issn0377-9777
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85140007640en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage397en_US
dc.identifier.trdizinid1126044en_US
dc.identifier.urihttps://doi.org/10.5505/TurkHijyen.2022.67355
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1126044
dc.identifier.urihttps://hdl.handle.net/20.500.14619/8798
dc.identifier.volume79en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherRefik Saydam National Public Health Agency (RSNPHA)en_US
dc.relation.ispartofTurk Hijyen ve Deneysel Biyoloji Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHepatitis b virusen_US
dc.subjectHepatitis c virusen_US
dc.subjectHiven_US
dc.subjectSeropositivityen_US
dc.subjectSeroprevalenceen_US
dc.titleHBsAg, Anti-HBs, Anti-HCV and Anti-HIV seroprevalence among patients admitted to our hospital; five-year retrospective dataen_US
dc.title.alternativeHastanemize başvuran hastalarda HBsAg, Anti-HBs, Anti-HCV ve Anti-HIV seroprevalansı: 5 yıllık retrospektif verien_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu